tiprankstipranks
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market

Monte Rosa Therapeutics (GLUE) Stock Investors

76 Followers
Based on 735,272 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GLUE
On average, investors allocate 0.00% of their portfolios to GLUE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 735,272 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding GLUE

1.4%
Last 7
Days
19.8%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GLUE, out of 735,272 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

GLUE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.25%
$6.70
Based on the activity of 13,868 investors who made their portfolios public
The table shows changes in GLUE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

GLUE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
ServiceNow
3.94%
-0.08%
+4.86%
159.30B
Technology
Coherus Biosciences
2.59%
-1.19%
-5.69%
238.63M
Healthcare
Raytheon Technologies
4.14%
-0.34%
-1.98%
140.17B
Industrials
Caterpillar
4.63%
-0.06%
+1.64%
175.60B
Industrials
DraftKings
6.15%
-0.06%
+0.99%
37.71B
Consumer Cyclical
Micron
5.72%
+0.60%
+2.29%
141.19B
Technology
Zscaler
3.71%
+0.36%
+2.51%
26.52B
Technology
Boeing
5.88%
-1.32%
-2.63%
113.43B
Industrials
Delta Air Lines
5.58%
-0.22%
-1.15%
33.70B
Industrials
GE Aerospace
5.43%
-0.89%
+0.19%
176.23B
Industrials
Based on the activity of 735,272 active portfolios
Open your Smart Portfolio

GLUE Investor Analysis

GLUE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
25.0%
of GLUE holders
are under 35
Average Segment Performance
Average P/E Ratio23.14
Beta6.02
Dividend Yield6.25%
GLUE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
50.0%
of GLUE holders
are between 35–55
Average Segment Performance
Average P/E Ratio22.00
Beta10.67
Dividend Yield6.42%
GLUE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
25.0%
of GLUE holders
are over 55
Average Segment Performance
Average P/E Ratio21.70
Beta3.83
Dividend Yield7.17%
Overview of age group and performance of GLUE stock investors
See who invests in GLUE according to age group and performance.

FAQ

How many retail Investors hold GLUE?
<0.1% of TipRanks' retail investors hold GLUE in their portfolios.
    What is GLUE Investor Sentiment?
    GLUE’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of GLUE in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of GLUE in the last 7 days.
        What percentage of retail investors changed their holding of GLUE in the last 30 days?
        ▲ 19.8% of TipRanks' retail investors changed their holding of GLUE in the last 30 days.
          What is the average age of retail investors who hold GLUE?
          The average age of GLUE Holders is between 35–55.
            What other stocks have GLUE investors also bought?
            GLUE Investors also bought NOW, CHRS, RTX, CAT, DKNG, MU, ZS, BA, DAL, GE.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              BDXBecton Dickinson
              BCRXBioCryst
              BSXBoston Scientific
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis